Halozyme Therapeutics, Inc. Insider Transactions
Halozyme Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Torley Helen
CEO |
Sell | 10,000 @ $57.95 | $579,490 | 676,744 | 08/15/2024 | 08/15/2024 | |
|
Torley Helen
CEO |
Sell | 3,263 @ $56.22 | $183,443 | 683,481 | 08/14/2024 | 08/15/2024 | |
|
Torley Helen
CEO |
Sell | 6,537 @ $57.73 | $377,394 | 676,944 | 08/14/2024 | 08/15/2024 | |
|
Torley Helen
CEO |
Sell | 200 @ $58.17 | $11,634 | 676,744 | 08/14/2024 | 08/15/2024 | |
|
Posard Matthew L.
Director |
Sell | 9,881 @ $57.70 | $570,134 | 69,874 | 08/14/2024 | 08/14/2024 | |
|
Torley Helen
CEO |
Sell | 10,000 @ $56.25 | $562,490 | 676,744 | 08/13/2024 | 08/15/2024 | |
|
Posard Matthew L.
Director |
Sell | 10,000 @ $56.19 | $561,930 | 79,755 | 08/13/2024 | 08/14/2024 | |
|
Posard Matthew L.
Director |
Sell | 10,000 @ $55.72 | $557,230 | 89,755 | 08/12/2024 | 08/14/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $55.12 | $551,150 | 168,176 | 07/24/2024 | 07/24/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 4,709 @ $54.46 | $256,466 | 173,467 | 07/23/2024 | 07/24/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 5,291 @ $55.27 | $292,407 | 168,176 | 07/23/2024 | 07/24/2024 | |
|
LaBrosse Nicole
SVP, CFO |
Sell | 4,008 @ $53.85 | $215,843 | 15,480 | 07/22/2024 | 07/23/2024 | |
|
LaBrosse Nicole
SVP, CFO |
Sell | 992 @ $54.25 | $53,819 | 15,480 | 07/22/2024 | 07/23/2024 | |
|
LaBrosse Nicole
SVP, CFO |
Sell | 10,000 @ $52.04 | $520,400 | 15,480 | 06/28/2024 | 06/28/2024 | |
|
LaBrosse Nicole
SVP, CFO |
Sell | 10,000 @ $51.93 | $519,340 | 15,480 | 06/27/2024 | 06/28/2024 | |
|
LaBrosse Nicole
SVP, CFO |
Sell | 10,000 @ $51.82 | $518,200 | 15,480 | 06/26/2024 | 06/28/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $49.43 | $494,260 | 168,176 | 06/18/2024 | 06/20/2024 | |
|
Posard Matthew L.
Director |
Sell | 10,000 @ $50.62 | $506,190 | 99,755 | 06/12/2024 | 06/13/2024 | |
|
Posard Matthew L.
Director |
Sell | 10,000 @ $50.01 | $500,110 | 109,755 | 06/11/2024 | 06/13/2024 | |
|
LaBarre Michael J.
SVP, CHIEF TECHNICAL OFFICER |
Sell | 10,000 @ $45.38 | $453,840 | 168,176 | 05/22/2024 | 05/22/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Halozyme Therapeutics, Inc. FAQ's
The list of insiders at Halozyme Therapeutics, Inc. includes LaBarre Michael J., Posard Matthew L., LaBrosse Nicole, Torley Helen.
Insiders have sold a total of 324,881 Halozyme Therapeutics, Inc. shares in the last 12 months for a total of 17.60 M sold.
The following insiders have sold Halozyme Therapeutics, Inc. shares in the last 12 months: LaBarre Michael J. ($6.82 M), Posard Matthew L. ($2.70 M), LaBrosse Nicole ($1.83 M), Torley Helen ($6.26 M),
The list of congress members trading at Halozyme Therapeutics, Inc. includes Josh Gottheimer.